Characteristics of 891 PTCL ≥ 70 years with PTCL according to location
| Variable . | CCR(N = 718) . | SLR(N = 173) . | P . |
|---|---|---|---|
| Sex | |||
| Male | 383 (53.3) | 101 (58.4) | .236 |
| Female | 335 (46.7) | 72 (41.6) | |
| Age > 80 y | |||
| No | 439 (61.1) | 126 (72.8) | .005 |
| Yes | 279 (38.9) | 47 (27.2) | |
| Age, y | |||
| 70-74 | 207 (28.8) | 59 (34.1) | .231 |
| 75-84 | 360 (50.1) | 86 (49.7) | |
| >84 | 151 (21.0) | 28 (16.2) | |
| Ann Arbor stage | |||
| I-II | 238 (36.2) | 42 (27.1) | .038 |
| III-IV | 420 (63.8) | 113 (72.9) | |
| Treatment | |||
| No | 333 (47.3) | 51 (29.8) | <.0001 |
| Yes | 371 (52.7) | 120 (70.2) | |
| Subtype | |||
| AITL | 192 (26.7) | 34 (19.7) | <.0001 |
| ALCL | 95 (13.2) | 27 (15.6) | |
| EATL | 15 (2.1) | 16 (9.2) | |
| Hepatosplenic TCL | 4 (0.6) | 3 (1.7) | |
| NK/TCL, nasal type | 55 (7.7) | 7 (4.0) | |
| PTCL, NOS | 357 (49.7) | 86 (49.7) | |
| CCI | |||
| 0 | 239 (38.9) | 65 (40.6) | .414 |
| 1 | 128 (20.8) | 39 (24.4) | |
| >1 | 248 (40.3) | 56 (35.0) |
| Variable . | CCR(N = 718) . | SLR(N = 173) . | P . |
|---|---|---|---|
| Sex | |||
| Male | 383 (53.3) | 101 (58.4) | .236 |
| Female | 335 (46.7) | 72 (41.6) | |
| Age > 80 y | |||
| No | 439 (61.1) | 126 (72.8) | .005 |
| Yes | 279 (38.9) | 47 (27.2) | |
| Age, y | |||
| 70-74 | 207 (28.8) | 59 (34.1) | .231 |
| 75-84 | 360 (50.1) | 86 (49.7) | |
| >84 | 151 (21.0) | 28 (16.2) | |
| Ann Arbor stage | |||
| I-II | 238 (36.2) | 42 (27.1) | .038 |
| III-IV | 420 (63.8) | 113 (72.9) | |
| Treatment | |||
| No | 333 (47.3) | 51 (29.8) | <.0001 |
| Yes | 371 (52.7) | 120 (70.2) | |
| Subtype | |||
| AITL | 192 (26.7) | 34 (19.7) | <.0001 |
| ALCL | 95 (13.2) | 27 (15.6) | |
| EATL | 15 (2.1) | 16 (9.2) | |
| Hepatosplenic TCL | 4 (0.6) | 3 (1.7) | |
| NK/TCL, nasal type | 55 (7.7) | 7 (4.0) | |
| PTCL, NOS | 357 (49.7) | 86 (49.7) | |
| CCI | |||
| 0 | 239 (38.9) | 65 (40.6) | .414 |
| 1 | 128 (20.8) | 39 (24.4) | |
| >1 | 248 (40.3) | 56 (35.0) |
Data are presented as no. (%) unless indicated otherwise.
ENKT CL, extranodal natural killer/T-cell lymphoma.